Literature DB >> 19813754

Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum.

Riham Salah El Dine1, Ali M El Halawany, Chao-Mei Ma, Masao Hattori.   

Abstract

A new farnesyl hydroquinone, ganomycin I (1), was isolated along with ganomycin B (2) from the chloroform extract of the fruiting bodies of the Vietnamese mushroom Ganoderma colossum. These compounds inhibited HIV-1 protease with IC50 values of 7.5 and 1.0 microg/mL, respectively. Kinetic studies using Zhang-Poorman and Lineweaver plots revealed that compound 2 competitively inhibited the active site of the enzyme, whereas the tetracyclic triterpene schisanlactone A, previously isolated from the same fungus, was a dimerization inhibitor, with an IC50 value of 5.0 microg/mL. The previous findings were also confirmed by the virtual docking of both compounds with HIV-1 protease crystal structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19813754     DOI: 10.1021/np900279u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

Review 1.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

Authors:  Arun K Ghosh; Heather L Osswald; Gary Prato
Journal:  J Med Chem       Date:  2016-01-22       Impact factor: 7.446

Review 2.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

3.  Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense.

Authors:  Ya Gao; Lihan Zhu; Jing Guo; Ting Yuan; Liqing Wang; Hua Li; Lixia Chen
Journal:  Oncotarget       Date:  2017-09-30

Review 4.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

Review 5.  Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update.

Authors:  Buddha Bahadur Basnet; Li Liu; Li Bao; Hongwei Liu
Journal:  Mycology       Date:  2017-05-24

6.  Terminal Cyclohexane-Type Meroterpenoids from the Fruiting Bodies of Ganoderma cochlear.

Authors:  Fu-Ying Qin; Te Xu; Yan-Peng Li; Hao-Xing Zhang; Dan Cai; Li-Zhong Liu; Yong-Xian Cheng
Journal:  Front Chem       Date:  2021-12-03       Impact factor: 5.221

Review 7.  Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.

Authors:  Nakarin Suwannarach; Jaturong Kumla; Kanaporn Sujarit; Thanawat Pattananandecha; Chalermpong Saenjum; Saisamorn Lumyong
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

8.  Cytotoxic and N-Acetyltransferase Inhibitory Meroterpenoids from Ganoderma cochlear.

Authors:  Li-Zhi Cheng; Fu-Ying Qin; Xiao-Chi Ma; Shu-Mei Wang; Yong-Ming Yan; Yong-Xian Cheng
Journal:  Molecules       Date:  2018-07-20       Impact factor: 4.411

9.  Triterpenes and Aromatic Meroterpenoids with Antioxidant Activity and Neuroprotective Effects from Ganoderma lucidum.

Authors:  Cuifang Wang; Xuemin Liu; Chenlei Lian; Jiaying Ke; Jieqing Liu
Journal:  Molecules       Date:  2019-11-28       Impact factor: 4.411

Review 10.  Antioxidant Activity of Mushroom Extracts/Polysaccharides-Their Antiviral Properties and Plausible AntiCOVID-19 Properties.

Authors:  Sechul Chun; Judy Gopal; Manikandan Muthu
Journal:  Antioxidants (Basel)       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.